Professor Maren Klawiter HTS 6110 Fall 2003

Medicine, Science, and Technology (with an emphasis on intersections with gender and sexuality)

This course is intended as a theoretically guided introduction to some of the key conceptual and substantive issues in the interdisciplinary field of medicine, science, and technology studies. Because the field is so large that no single course could cover its entire breadth, I have chosen to emphasize health sciences and technologies in the U.S. (biomedical and public health), with an emphasis on the ways in which health- related institutions, sciences, and technologies intersect with, shape, and are shaped by the institution of gender. This course also emphasizes the manifold ways in which the institutions of science, medicine, and public health are being challenged by social groups formerly excluded from, marginalized within, or demonized and dominated by these institutions. Finally, this course pays particular attention to the growing power and ubiquity of drugs and the pharmaceutical industry.

Seminar Grades will be based on the following:

o 25% written analysis of the week’s readings and leadership of the seminar discussion o The written analysis should be circulated to seminar participants by Tuesday night, at the latest. o 25% seminar participation o attending every seminar o coming to the seminar well-prepared (This means that you’ve not only read the assigned materials, but you’ve actually thought about them, engaged with them, and taken notes on them. You’ve also carefully read and considered the pre-circulated analysis of the readings, and you’ve thought in advance about what you want to talk about during the seminar disucssion. o participating actively in the seminar (This means participating actively in the seminar.) o 50% final paper o 20-25 pages of text (not including footnotes and bibliography) o You should figure out what kind of a paper you want to write by the end of October, at the very latest. o There will be no late papers or incompletes.

Possible Paper Formats

o You may write a research paper on a topic of your own choosing related to the couse. You can use any theory or theme or topic in the course as a starting point. 2

Alternatively, you might wish to pursue science, medicine and technology-related aspects of a problem you are already involved in studying and researching. o You may develop a research proposal related to any theme or topic in the course. The research proposal must include a critical literature review, fairly ambitious and well-focused. o You may write a more theoretical paper. You could compare two or more theories, or two bodies of theory; or you could, for example, use two different theoretical perspectives to analyze a particular topic or issue. o You may develop an alternative project as long as you secure my approval well in advance of the due date (by the end of October, at the latest).

Required Books

o Adele Clarke and Virginia Olesen, eds., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999). o Jonathan Metzl, Prozac on the Couch: Prescribing Gender in the Era of Wonder Drugs (Duke University Press, 2003) o Harry M. Marks, The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 (Cambridge University Press, 1997) o Deborah Lupton, The Imperative of Health: Public Health and the Regulated Body (Sage, 1995) [if searching for this title on amazon.com, try the search using “governing the masses”] o Steve Kroll-Smith, Phil Brown, and Valerie J. Gunter, ed., Illness and the Environment: A Reader in Contested Medicine (New York University Press, 2000)

Background Reading (recommended)

o Paul Starr, The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry (Basic Books, 1984) o Bryan S. Turner, Medical Power and Social Knowledge, 2nd edition (Sage, 1997) o Peter Conrad, ed., The Sociology of Health and Illness, sixth edition (Worth-St. Martin’s Press, 2001) OR Chloe E. Bird, Peter Conrad, and Allen Fremont, eds., Handbook of Medical Sociology, 5th edition (Prentice Hall, 2000). o Donald MacKenzie and Judy Wajcman, eds., The Social Shaping of Technology, 2nd edition (Open University Press, 1999) o David J. Hess, Science Studies: An Advanced Introduction (New York University Press, 1997)

Week 1 [aug 20] Introduction and Overview

o Adele Clarke and Virginia Olesen, “Revising, Diffracting, Acting,” pp. 3-46 in Adele Clarke and Virginia Olesen, ed., 3

Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999).

Week 2 [aug 27] The Social Construction of Disease

o William Rothstein, “Disease as a Social Concept” in Rothstein, ed., Readings in American Health Care: Current Issues in Socio-Historical Perspective (Madison, WI: University of Wisconsin Press), pp. 87-98. o Phil Brown, “Naming and Framing: The Social Construction of Diagnosis and Illness,” Journal of Health and Social Behavior (1995, extra issue): 34-52. o Ann Figert, “The Three Faces of PMS: The Professional, Gendered, and Scientific Structuring of a Psychiatric Disorder,” Social Problems 42 (1995): 56-73. o Elizabeth Armstrong, “Diagnosing Moral Disorder: The Discovery and Evolution of Fetal Alcohol Syndrome,” Social Science & Medicine 47 (1998): 2025-2042.

The Social Construction of Cancer: 4 Perspectives

o Barron Lerner, “Inventing a Curable Disease: Historical Perspectives on Breast Cancer” in Anne Kasper and Susan Ferguson, eds., Breast Cancer: Society Shapes an Epidemic (New York: St. Martins Press, 2000), pp. 25-50. o Robert N. Proctor, “Introduction: What Do We Know?”and Chapter 5, “‘Doubt Is Our Product’: Trade Association Science,” in Cancer Wars: How Politics Shapes What We Know & Don’t Know About Cancer (New York: Basic Books, 1995), pp. 1-15 and 101-132.. o Paula Lantz and Karen Booth, “The Social Construction of the Breast Cancer Epidemic” Social Science & Medicine 46 (1998): 907-918. o Maren Klawiter, “Racing for the Cure, Walking Women, and Toxic Touring: Mapping Cultures of Action within the Bay Area Terrain of Breast Cancer,” Social Problems 46 (1999): 104-126.

Recommended Readings o Charles Rosenberg, “Disease in History: Frames and Framers,” Milbank Quarterly 67 (Suppl. 1): 1-15. o Elizabeth Armstrong, Conceiving Risk, Bearing Responsibility (Johns Hopkins University Press, 2003) 4

o [rec] Keith Wailoo, Drawing Blood: Technology and Disease Identity in Twentieth-Century America (Johns Hopkins University Press, 1997) o [rec] F. B. McCrea, “The politics of menopause: the ‘discovery’ of a deficiency disease,” Sociology of Health and Illness: Critical Perspectives, eds. P. Conrad and R. Kern (New York: St. Martin’s Press, 1986). o [rec] Barron H. Lerner, Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth-Century America (Oxford University Press, 2001) o [rec] Judith Lorber, Gender and the Social Construction of Illness (London: Sage, 1997).

Week 3 [sept 3] Medicalization and Social Control

Medicalization Theory o Barbara Ehrenreich and John Ehrenreich, “Medicine and Social Control,” in The Cultural Crisis of Modern Medicine, ed. John Ehrenreich (Monthly Review Press, 1978), 39-79. [e-reserves] o Peter Conrad, “Medicalization and Social Control,” Annual Review of Sociology 18 (1992): 209-232. [e-reserves] o Kathryn Pauly Morgan, “Contested Bodies, Contested Knowledges: Women, Health, and the Politics of Medicalization,” pp. 83-121 in The Politics of Women’s Health: Exploring Agency and Autonomy, ed. The Feminist Health Care Ethics Research Nework (Philadelphia: Temple University Press, 1998). [e-reserves] o Simon Williams and Michael Calnan (1996). The 'Limits' of Medicalization: Modern Medicine and the Lay Populace in 'Late Modernity'. Social Science and Medicine, 42, 1609- 1620. [e-reserves] o Adele Clarke, Janet Shim, Laura Mamo, Jennifer Fosket, Jennifer Fishman (2003). Biomedicalization: Theorizing Technoscientific Transformation of Health, Illness, and U.S. Biomedicine. American Sociological Review, 68, 161-194.

Case Studies of Medicalization

o Susan Bell, “Sociological Perspectives on the Medicalization of Menopause” in M. Flint and F. Kronenberg, and W. Utian, eds., Multidisciplinary Perspectives on Menopause (New York: New York Academy of Sciences, 1990), pp. 173-178. [e-reserves] 5

o Iris Lopez, “An ethnography of the medicalization of Puerto Rican women’s reproduction,” pp. 240-259 in Margaret Lock and Patricia Kaufert, ed., Pragmatic Women and Body Politics (Cambridge University Press, 1998). [e-reserves] o I. Kawachi and Peter Conrad, “Medicalization and the Pharmacological Treatment of Blood Pressure” in Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs (Oxford University Press), pp. 26-41. [e-reserves] o Maren Klawiter, “Risk, Prevention and the Breast Cancer Continuum: The NCI, the FDA, Health Activism and the Pharmaceutical Industry,” History and Technology 18 (2002): 309-353. [e-reserves] o Shirley Lee and Avis Mysyk, “The Medicalization of Compulsive Buying,” in-press, Social Science & Medicine, 2003. [e-reserves]

Recommended Readings

o [rec] Irving K. Zola, “Medicine as an Institution of Social Control,” Sociological Review 20 (1972): 480-504. o [rec] Dorothy Nelson and Laurence Tancredi, Dangerous Diagnostics: The Social Power of Biological Information (University of Chicago Press, 1989) o [rec] Simon J. Williams and Michael Calnan, “The ‘Limits’ of Medicalization?: Modern Medicine and the Lay Populace in ‘Late Modernity,’” Social Science & Medicine 42 (1996): 1609-1620. o [rec] Adele Clarke Janet Shim, Laura Mamo, Jennifer Ruth Fosket, Jennifer Fishman, “Biomedicalization: Technoscientific Transformation of Health, Illness, and U.S. Biomedicine,” American Sociological Review 68 (2003): 161-194. o [rec] Peter Conrad and Joseph Schneider, Deviance and Medicalization: From Badness to Sickness, expanded edition (Temple University Press, 1992) o [rec] Peter Conrad and Deborah Potter, “From Hyperactivity to Adult ADHD: Observations on Expanding Medical Categories,” Social Problems 47 (November 2000): 559-582. o [rec] Verta Taylor, Rock-a-by-baby: Feminism, Self-Help, and Postpartum Depression (New York: Routledge, 1996), xiii- xvi, pp. 1-23. o [rec] Jacqueline Litt, Medicalized Motherhood (Rutgers University Press, 2002)

** viewing of pharma commercials compiled by Joe Dumit ** 6

Week 4 [sept 10] Drugs and the Pharmaceutical Industry (Week 1: Focus on Gender)

o Jonathan Metzl, Prozac on the Couch: Prescribing Gender in the Era of Wonder Drugs (Duke University Press, 2003) o Laura Mamo and Jennifer Fishman, “Potency in all the right places: Viagra as a technology of the gendered body,” Body and Society 7 (2001): 13-35. [e-reserves] o Alison Keith, “The Economics of Viagra,” Health Affairs 19 (March/April 2000): 147-157. [e-reserves]

o [rec] L. M. Finley, “The pharmacetuical industry and women’s reproductive health: The perils of ignoring risk and blaming women, “ in E. Szockyj and J. Fox (eds), Corporate Victimization of Women (Boston: Northeastern University Press, 1996), pp. 59-110. o [rec] Jonathan Metzl, “Mother’s Little Helper …,” Gender & History 15 (August 2003): 228-255.

Week 5 [sept 17] Drugs and the Pharmaceutical Industry (Week 2)

o Nancy Vuckovic and Mark Nichter, “Changing Patterns of Pharmaceutical Practice in the United States,” Social Science and Medicine 44 (1997): 1285-1302. [e-reserves] o Michael Wilkes, Robert Bell, and Richard Kravitz, “Direct- To-Consumer Prescription Drug Advertising: Trends, Impact, and Implications,” Health Affairs 18 (March/April 2000): 110-128. [e-reserves] o Richard Rettig, “The Industrialization of Clinical Research,” Health Affairs 18 (March/April 2000): 129-146. o John Abraham and Tim Reed, “Progress, innovation and regulatory science in drug development: the politics of international standard-setting,” Social Studies of Science 32 (June 2002): 337-369. [e-reserves] o Adele Clarke and Theresa Montini, “The Many Faces of RU486: Tales of Situated Knowledges and Technological Contestations,” Science, Technology, and Human Values 18 (1993): 42-78. [e-reserves] o Vivien Walsh and Jordan Goodman, “Cancer chemotherapy, 7

biodiversity, public and private property: the case of the anti- cancer drug Taxol,” Social Science and Medicine 49 (1999): 1215-1225 [e-reserves] o Steve Epstein, “Activism, Drug Regulation, and the Politics of Therapeutic Evaluation in the AIDS Era: A Case Study of ddC and the ‘Surrogate Markers’ Debate,” Social Studies of Science 27 (1997): 691-726. [e-reserves] o Donald G. McNeil, Jr., “Drug Companies and Third World: A Case Study in Neglect,” New York Times, Sunday May 21, 2000. (This is part of a series of articles on the pharmaceutical industry called “Medicine Merchants,” published between April and July of 2000) [e-reserves]

o [rec] David Healy, The Antidepressant Era (Harvard University Press, 1997) o [rec] Nikolas Rose, “Becoming Neurochemical Selves,” paper presented at Biotechnology, Commerce and Civil Society Conference (September 5-7, 2002), in Essen, Germany o [rec] Jordan Goodman and Vivien Walsh, The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug (Cambridge University Press, 2001).

Week 6 [sept 24] Clinical Research and the Production of Medical Knowledge (Week 1)

o Harry M. Marks, The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 (Cambridge University Press, 1997). o Karin Garrety, “Social Worlds, Actor-Networks and Controversy: The Case of Cholesterol, Dietary Fat and Heart Disease,” Social Studies of Science 27 (1997): 727-773. [e- reserves]

Recommended Readings o [rec] Janet Shim, “Bio-power and racial, class, and gender formation in biomedical knowledge production” in J.J. Kronenfeld, ed., Research in the sociology of health care, volume 17 (Stamford, CT: JAI Press, 2000), pp. 173-195. 8

Week 7 [oct 1] Clinical Research and the Production of Medical Knowledge (Week 2)

o Nancy Krieger and Elizabeth Fee, “Man-made medicine and women’s health: The biopolitics of sex/gender and race/ethnicity” in Fee and Krieger, eds. Women’s health, politics, and power: Essays on sex/gender, medicine, and public health (Amityville, NY: Baywood, 1994), pp. 1-30. [e-reserves] o T. Johnson and Elizabeth Fee, “Women’s participation in clinical research: From protectionism to access” in A.C. Mastroianni, R. Faden, and D. Federman, eds., Women and health research: Ethical and legal issues of including women in clinical studies, Volume 2: Workshop and commissioned papers (Washington DC: National Academy Press), pp. 1-10. [e-reserves] o Janet L. Mitchell, “Recruitment and Retention of Women of Color in Clinical Studies,” in A.C. Mastroianni, R. Faden, and D. Federman, eds., Women and health research: Ethical and legal issues of including women in clinical studies, Volume 2: Workshop and commissioned papers (Washington DC: National Academy Press), pp. 52-56. [e-reserves] o Sue Rosser, “Gender bias in clinical research: The difference it makes” in A. Dan, ed., Reframing women’s health: Multidisciplinary research and practice (Thousand Oakes, CA: Sage, 1994), pp. 253-265. [e-reserves] o Steven Epstein, “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials,” Science, Technology & Human Values 20, no. 4 (Autumn 1995): 408-437. [e-reserves] o Steve Epstein, “Sexualizing Governance and Medicalizing Identities: The Emergence of ‘State-Centered’ LGBT Health Politics in the United States,” Sexualities 6 (2003): 131-171. o Nelly Oudshoorn, “On masculinities, technologies, and pain: The testing of male contraceptives in the clinic and the media,” Science, Technology and Human Values 24 (1999): 265-289. [e-reserves]

Week 8 [oct 8] Sci-Tech-Med Studies and Foucault: Key Concepts and Contributions

o Michel Foucault, “Preface” (ix-xix) and “Seeing and Knowing”(107-123) in Birth of the Clinic, pp. TBA [e- reserves] 9

o Michel Foucault, “Introduction,” “Preface” (v-xii) and “The Great Confinement” (chapter 2, pp. 38-64) in Madness and Civilization [e-reserves] o Michel Foucault, “Panopticism” (Part III, chapter 3) in Discipline and Punish, pp. 195-228. [e-reserves] o Michel Foucault, “Right of Death and Power over Life,” Part V of History of Sexuality, v1, pp. 133-159. [e- reserves] o Deborah Lupton, “Foucault and the medicalisation critique,” pp. 94-110 in Alan Petersen and Robin Bunton, ed., Foucault: Health and Medicine (Routledge, 1997). [e-reserves] o Carl Elliott, “A new way to be mad,” The Atlantic Monthly, Dec 2000; Vol. 286, Iss. 6; pg. 72-83. [e- reserves]

Recommended Readings o [rec] Nancy Fraser, “Foucault on Modern Power: Empirical Insights and Normative Confusions,” Unruly Practices: Power, Discourse and Gender in Contemporary Social Theory (University of Minnesota Press, 1989). pp. 17-34. o [rec] Dorothy Nelson and Laurence Tancredi, Dangerous Diagnostics: The Social Power of Biological Information (University of Chicago Press, 1989)

Week 9 [oct 15] The Self and Regimes of Public Health and Medicine

o David Armstrong, “The Rise of Surveillance Medicine,” Sociology of Health & Illness 17 (1995): 393-404. [e- reserves] o Deborah Lupton, The Imperative of Health: Public Health and the Regulated Body (Sage, 1995) o Robin Bunton and Roger Burrows, “Consumption and health in the ‘epidemiological’ clinic of late modern medicine,” pp. 206-222 in Robin Bunton, Sarah Nettleton and Roger Burrows, ed., The Sociology of Health Promotion: Critical Analyses of Consumption, Lifestyle, and Risk (New York: Routledge, 1995. [e-reserves]

Recommended Readings o [rec] David Armstrong, “Public Health Spaces and the Fabrication of Identity,” Sociology 27 (1993): 393-410. 10

o [rec] Robert Castel, “From Dangerousness to Risk,” in Graham Burchell, Colin Gordon and Peter Miller (eds.) The Foucault Effect: Studies in Governmentality (Chicago: University of Chicago Press, 1991), pp. 281- 298. o [rec] Claudine Herzlich and Janine Pierret, Illness and Self in Society (Johns Hopkins University Press, 1987). o [rec] Arthur Frank, The Wounded Storyteller: Body, Illness, and Ethics (University of Chicago Press, 1995). o [rec] Martha Balshem, Cancer in the Community: Class and Medical Authority (Washington D.C.: Smithsonian Institution Press, 1993).

Week 10 [oct 22] Environmental Sciences, Illnesses & Activism

Steve Kroll-Smith, Phil Brown, and Valerie J. Gunter, ed., Illness and the Environment: A Reader in Contested Medicine (New York University Press, 2000). Read select chapters incl. the following:

o Introduction and Chapter 1 (pp. 1-28) o Steve Wing, “Limits of Epidemiology” (pp. 29-45) o Steve Kroll-Smith and H. Hugh Floyd, “Environmental Illness as a Practical Epistemology and a Source of Professional Confusion” (pp. 72-94) o Stella M. Čapek, “Reframing Endometriosis: From ‘Career Woman’s Disease’ to Environment/Body Connection” (pp. 345-363) o Phil Brown, “Popular Epidemiology and Toxic Waste Contamination: Lay and Professional Ways of Knowing” (pp. 364-383)

Read Also: o Phil Brown, Stephen Zavestoski, Meadow Linder, Sabrina McCormick, and Brian Mayer, “Chemicals and Casualties: The Search for Causes of Gulf War Illnesses,” pp. 213-236 in Monica Casper, ed., Synthetic Planet: Chemical Politics and the Hazards of Modern Life (Routledge, 2003). [e- reserves] o Hilary Arksey, “Expert and Lay Participation in the Construction of Medical Knowledge,” Sociology of Health & Illness 16, no. 4 (1994): 448-468. [e-reserves] o Jennifer Fishman, “Breast cancer: Risk, science, and 11

environmental activism in an ‘at risk’ community” in Laura Potts, ed., Ideologies of breast cancer: Feminist perspectives (New York: St. Martin’s Press, 2002), pp. 181-204. [e- reserves]

Recommended Readings: o [rec] J. Stephan Kroll-Smith, H. Hugh Floyd, and Steven Kroll, Bodies in Protest: Environmental Illness and the Struggle Over Medical Knowledge (New York University Press, 1997) o [rec] Sandra Steingraber, Living Downstream: An Ecologist Looks at Cancer and the Environment (Addiso-Wesley Publishing Company, 1997)

Week 11 [oct 29] Feminist Theory, Methods, and Epistemology

Theoretical Speculations and Interventions o Adele Clarke and Virginia Olesen, “Revising, Diffracting, Acting,” pp. 3-46 in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999). o Donna Haraway, “The Virtual Speculum in the New World Order,” pp. 49-96 in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999). o Emily Martin, “The Woman in the Flexible Body,” pp. 97-118 in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999). o Sandra Harding, “Postcolonial Science and Technology Studies: A Space for New Questions” and “Postcolonial Feminist Science Studies: Resources, Challenges, Dialogues” in Is Science Multi-Cultural? Postcolonialisms, Feminisms, and Epistemologies (Indiana University Press, 1998), pp. 73- 88. [e-reserves] o Laura Briggs, “Discourses of ‘forced sterilization’ in Puerto Rico: The problem with the speaking subaltern,” Differences 10 (1998): 30-65. [e-reserves]

Destabilizing Methods 12

o Rayna Rapp, “One new reproductive technology, multiple sites: How feminist methodology bleeds into everyday life,” pp. 119-135 in Adele Clarke and Virginia Olesen, eds., Revisioning women, health, and healthing: Feminist, cultural, and technoscience perspectives (New York: Routledge, 1999). o Patti Lather, “Naked Methodology: Researching the Lives of Women with HIV/AIDS,” pp. 136-154 in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999). o Denise Segura and Adela de la Torre, “La Sufrida: Controdictions of Acculturation and Gender in Latina Health,” pp. 155-165” in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999).

Recommended Readings o [rec] Donna Haraway, Simians, Cyborgs and Women: The Reinvention of Nature (1991) [see especially “A Cyborg Manifesto” and “Situated Knowledges”] o [rec] Evelyn Fox Keller, “The Origin, History and Politics of the Subject Called ‘Gender and Science’: A First Person Account” in Sheila Jasanoff, et al., ed. Handbook of Science and Technology Studies (Thousand Oaks: Sage, 1995), pp. 80-94. o [rec] Judy Wajcman, “Feminist Theories of Technology” in Sheila Jasanoff, et al., ed. Handbook of Science and Technology Studies (Thousand Oaks: Sage, 1995), pp. 189- 204. o [rec] Elizabeth Grosz, Volatile Bodies: Toward a Corporeal Feminism (Bloomington, IN: Indiana University Press, 1994)

Week 12 [nov 5] Medical Practices & Technologies (with a Focus on Reproductive and Imaging Technologies)

o Monica Casper and M. Berg, “Constructivist Perspectives on Medical Work: Medical Practices and Science and Technology Studies,” Science, Technology and Human Values 18 (1995): 42-78. [e-reserves] o Stefan Timmermans, “Technology and Medical Practice” 13

in Chloe Bird, Peter Conrad, Allen Fremont, ed., Handbook of Medical Sociology, 5th edition (Prentice Hall, 2000), pp. 309-321. [e-reserves] o Lisa Cartwright, “Women and the Public Culture of Radiography” in Lisa Cartwright, Screening the Body: Tracing Medicine’s Visual Culture (University of Minnesota Press, 1995), pp. 143-170. [e-reserves] o Anne Balsamo, “Public Pregnancies and Cultural Narratives of Surveillance,” pp. 231-253 in Adele Clarke and Virginia Olesen, ed., Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives (New York: Routledge, 1999) o Carol Stabile, “Shooting the Mother: Fetal Photography and the Politics of Disappearance,” pp. 171-197 in Paula Treichler, Lisa Cartwright and Constance Penley, ed., The Visible Woman: Imaging Technologies, Gender, and Science (New York University Press, 1998) [e-reserves] o Rayna Rapp, “Refusing Prenatal Diagnosis: The Meanings of Bioscience in a Multicultural World,” Science, Technology, and Human Values 23 (1998): 45- 70. [e-reserves] o Andrea Tone, “Making Room for Rubbers: Gender, Technology, and Birth Control Before the Pill,” History and Technology 18 (2000): 51-76. [e-reserves]

Recommended Readings o [rec] Andrea Tone, “Violence by Design: Contraceptive Technology and the Invasion of the Female Body” in Michael Bellesiles, ed., Lethal Imagination: Violence and Brutality in American History (New York University Press, 1999), pp. 373-391. o [rec] Cynthia R. Daniels, “The Social Construction of Male Reproduction and the Politics of Fetal Harm,” Women, Science and Technology, ed. Mary Wyer et al. (Routledge, 2001), pp. 312-331. o [rec] Faye Ginsberg and Rayna Rapp, eds., Conceiving the New World Order: The Global Stratification of Reproduction (Berkeley: University of California Press, 1995). o [rec] Nelly Oudshoorn, Beyond the Natural Body: An Archaeology of Sex Hormones (New York: Routledge, 1994). o [rec] Paula Treichler, Lisa Cartwright, and C. Penley, eds., 14

The visible woman: Imaging technologies, gender, and science (New York University Press, 1998).

Geneticization Week 13 [nov 12] o Abby Lippman, “The Politics of Health: Geneticization Versus Health Promotion” [e-reserves] o Shobita Parthasarathy, “Knowledge is Power: Genetic Testing for Breast Cancer and Patient Activism in the United States and Britain,” in Trevor Pinch and Nelly Oudshoorn, ed., How Users Matter (MIT Press, 2003) [e-reserves] o Paul Rabinow, “Artificiality and Enlightenment: From Sociobiology to Biosociality,” [e-reserves] o Jennifer Reardon, “The Human Genome Diversity Project: A Case of Coproduction,” Social Studies of Science 31 (2001): 357-388. [e-reserves] o Ruth Hubbard and E. Wals, “The eugenics of normalcy: The politics of gene research,” The Ecologist 23, n 5 (1993): 185- 191. [e-reserves]

Recommended Readings o [rec] Robert N. Proctor, “Genetic Hopes” in Cancer Wars: How Politics Shapes What We Know & Don’t Know About Cancer (New York: Basic Books, 1995), pp. 217-247. o [rec] Ruth Hubbard and Elijah Wald, Exploding the Gene Myth o [rec] Robert Bud, “Biotechnology in the Twentieth Century,” Social Studies of Science 21 (1991): 415-457. o [rec] Troy Duster, Backdoor to Eugenics, 2nd ed. (Routledge, 2003) o [rec] Stephen Hilgartner, “The Human Genome Project” in Sheila Jasanoff, et al., ed. Handbook of Science and Technology Studies (Thousand Oaks: Sage, 1995), pp. 302- 316. o [rec] Peter Conrad, “Medicalization, Genetics, and Human Problems” in Chloe E. Bird, Peter Conrad, and Allen Fremont, eds., Handbook of Medical Sociology, 5th edition (Prentice Hall, 2000).

Week 14 [nov 19] FLOATING WEEK for RESEARCH 15

Group Dinner--Papers Due Week 15 [dec 3] (no incompletes will be granted)